2017-12-15T15:04:31-06:00 2017-06-30 GRANT THORNTON LLP 171 N CLARK ST SUITE 200 CHICAGO IL 60601 990 2016-07-01 133039601 Alzheimer's Disease & Related Disorders Association Inc % RICHARD HOVLAND ALZH 3123358700 225 N Michigan Ave 17th Floor Chicago IL 606017633 RICHARD H HOVLAND COO/CFO 3123355771 2017-12-15 true Bridget T Roche P00666837 3128560200 38.84.128.189 36941220173495000007 2017-12-15 P 8570B2D8046878F456576E706BB8FB99030C32C0 D82AAF40F04826B5094FBA4B72FF1F4790CA5AE8 2016 2018-03-14 21:41:22Z Alzheimer's Association Richard H Hovland 225 N Michigan Ave 17th Fl Chicago IL 606017633 355945511 false X www.alz.org X 1980 DE ELIMINATE ALZHEIMER'S DISEASE THROUGH THE ADVANCEMENT OF RESEARCH, PROVIDE & ENHANCE CARE & SUPPORT FOR ALL AFF- ECTED & REDUCE THE RISK OF DEMENTIA THROUGH PROMOTION OF BRAIN HEALTH. 29 29 2307 56000 0 0 160287157 303300791 4604129 9746976 3015131 6179743 4815214 8231840 172721631 327459350 27721311 32350336 0 0 55842348 160816980 1248859 1310457 56097504 80289888 133673989 165102406 328151762 7619225 -692412 197241986 345089789 65411846 77223643 131830140 267866146 X THE ALZHEIMER'S ASSOCIATION IS THE LEADING VOLUNTARY HEALTH ORGANIZATION IN ALZHEIMER CARE, SUPPORT, AND RESEARCH. (MISSION CONTINUED IN SCHEDULE O). false false 183962755 3069223 177026 PUBLIC AWARENESS AND EDUCATION - ALZHEIMER'S IS A PROGRESSIVE, DEGENERATIVE AND ULTIMATELY FATAL DISEASE. TOO FEW AMERICANS UNDERSTAND THE CURRENT AND FUTURE ECONOMIC IMPACT OF ALZHEIMER'S. ALREADY MORE THAN 5 MILLION AMERICANS ARE LIVING WITH ALZHEIMER'S AND AS MANY AS 15 MILLION PEOPLE ARE PROVIDING UNPAID CARE AND SUPPORT. AND THIS MASSIVE GROUP IS IN NEED OF INFORMATION AND RESOURCES. THE ALZHEIMER'S ASSOCIATION HAS INVESTED IN EDUCATION CAMPAIGNS AND INITIATIVES TO INCREASE KNOWLEDGE ABOUT ALZHEIMER'S DISEASE AND AWARENESS OF THE ALZHEIMER'S ASSOCIATION COMMUNICATING OUR ROLE AS LEADERS OF THE CAUSE. KEY MESSAGES INCLUDE THE IMPORTANCE OF EARLY DETECTION, RESOURCES FOR PEOPLE WITH ALZHEIMER'S AND THEIR FAMILIES, AND THE SOCIETAL IMPACT OF THE DISEASE. MILLIONS OF CONSTITUENTS PARTICIPATED IN OUR PROGRAMS IN LOCAL COMMUNITIES AND ON-LINE. 40534601 27656078 8476188 RESEARCH - THE ALZHEIMER'S ASSOCIATION IS ON THE FOREFRONT OF THE ALZHEIMER'S SCIENTIFIC FIELD, GLOBALLY CONNECTING RESEARCHERS IN THE QUEST TO FIND METHODS OF TREATMENT, PREVENTION AND A CURE. THE ALZHEIMER'S ASSOCIATION IMPLEMENTS AN AGGRESSIVE GLOBAL RESEARCH AND SCIENCE PROGRAM STRATEGICALLY DESIGNED TO ACCELERATE PROGRESS BY FOSTERING INNOVATION, IDENTIFYING AND CLOSING CRITICAL KNOWLEDGE GAPS, DEVELOPING AND DISSEMINATING TOOLS, AND NURTURING SCIENTIFIC TALENT. THE ALZHEIMER'S ASSOCIATION HAS BEEN A CATALYST AND CONVENER FOR MORE THAN 30 YEARS. WHETHER FUNDING INNOVATIVE GRANTS TO HELP FURTHER TREATMENTS AND DISCOVERY, HOSTING THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE (AAIC*), THE WORLD'S LARGEST GATHERING OF ALZHEIMER'S RESEARCHERS, OR LEADING ENDEAVORS LIKE THE WORLDWIDE ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE (WW-ADNI) TO ACCELERATE ADVANCES IN IMAGING, THE ALZHEIMER'S ASSOCIATION SEEKS TO FUND AND ADVANCE BEST-IN-CLASS RESEARCH AND WORKS WITH COLLABORATORS AROUND THE GLOBE FROM ALL SECTORS TO HASTEN THIS PROGRESS. * These are names that are trademarks to Alzheimer's Association 11951764 1270788 CHAPTER SERVICES - 81 CHAPTERS ARE IN COMMUNITIES NATIONWIDE, PROVIDING SERVICES TO FAMILIES AND PROFESSIONALS, INCLUDING INFORMATION AND REFERRAL, SUPPORT GROUPS, CARE CONSULTATION, EDUCATION AND SAFETY SERVICES. 15892366 1625035 252341486 true true false true false false false false false true true true false false true true false true false false true true false true true true false true true true false false false false false false false true true false false false false true true true true false true 779 1 true 2307 true false false false false false true true false false false false X 29 29 false false false false false false false true true false true true true true true true true true true true false AL AK AR CA CT DC FL GA IL KS KY ME MD MA MI MN MS NH NJ NM NY NC OK OR PA RI SC TX UT VA WA WV WI X X X RICHARD HOVLAND 3123355771 225 N MICHIGAN AVE 17TH FLOOR Chicago IL 606017633 Stewart Putnam Thru 1016 Chair, Exec. Comm., Director 12.0 0.0 X X 0 0 0 Christopher BinkleyBEG 1016 Chair, Exec. Comm., Director 12.0 0.0 X X 0 0 0 Deborah Jones Thru 1016 Secretary, Exec. Comm., Dir. 10.0 0.0 X X 0 0 0 Thomas J Winkel Thru 1016 Treasurer, Exec. Comm., Dir. 10.0 0.0 X X 0 0 0 Bill Buechele Treasurer, Exec. Comm., Dir. 10.0 0.0 X X 0 0 0 Jack Faer Director and Exec Committee 5.0 0.0 X 0 0 0 Marlana GehaPhD Thru 1016 Director and Exec Committee 5.0 0.0 X 0 0 0 David Goltermann Director and Exec Committee 5.0 0.0 X 0 0 0 Louis Holland Jr Director and Exec Committee 5.0 0.0 X 0 0 0 Paul Hornback BEG 1016 Director and Exec Committee 5.0 0.0 X 0 0 0 William E Klunk MD PhD Dir & Exec Comm (Thru 10/16) 5.0 0.0 X 0 0 0 David Knopman MDBEG 1016 Director and Exec Committee 5.0 0.0 X 0 0 0 Jacqueline Kouri Secretary, Exec. Comm., Dir. 10.0 0.0 X X 0 0 0 Margaret Noel MD Director and Exec Committee 5.0 0.0 X 0 0 0 Ronald Petersen MD PhD Dir & Exec Comm (Thru 10/16) 5.0 0.0 X 0 0 0 Debra Pierson BEG 1016 Director and Exec Committee 5.0 0.0 X 0 0 0 Kimberly Reed Director and Exec Committee 5.0 0.0 X 0 0 0 Karen Stevenson BEG 1016 Director and Exec Committee 5.0 0.0 X 0 0 0 Carolyn Tieger BEG 1016 Director and Exec Committee 5.0 0.0 X 0 0 0 Carl E Tuerk JrThru 1016 Director and Exec Committee 5.0 0.0 X 0 0 0 Derek van Amerongen Dir & Exec Comm (BEG. 10/16) 5.0 0.0 X 0 0 0 Electa Anderson Director 5.0 0.0 X 0 0 0 Helen Brooks Director 5.0 0.0 X 0 0 0 Anna Catalano Director 5.0 0.0 X 0 0 0 James Grossmann Director 5.0 0.0 X 0 0 0 David Hunter Director 5.0 0.0 X 0 0 0 Verna Jones-Rodwell Director 5.0 0.0 X 0 0 0 Diana Kerwin MD Director 5.0 0.0 X 0 0 0 Sarah Lorance Director 5.0 0.0 X 0 0 0 Ralph Nixon MD PhD Director 5.0 0.0 X 0 0 0 Robert O'Keefe Director 5.0 0.0 X 0 0 0 Steven Osgood Director 5.0 0.0 X 0 0 0 Cecile Perich Director 5.0 0.0 X 0 0 0 Patrick Peyton Thru 1016 Director 5.0 0.0 X 0 0 0 Brian Richardson Director 5.0 0.0 X 0 0 0 Alan Silverglat Thru 1016 Director 5.0 0.0 X 0 0 0 David Simbro Thru 1016 Director 5.0 0.0 X 0 0 0 Joan Uronis Thru 1016 Director 5.0 0.0 X 0 0 0 Julia Wallace Director 5.0 0.0 X 0 0 0 Paul Wexler Director 5.0 0.0 X 0 0 0 HARRY JOHNS President & CEO 60.0 0.13 X 856846 1539 251073 RICHARD HOVLAND COO/CFO 60.0 0.08 X 516475 522 98314 Christine Foh Asst Secy & VP Legal & GC 60.0 0.03 X 242347 96 37832 Maria Carrillo Chief Science Officer 60.0 0.0 X 420614 0 59255 Robert Egge Chief Public Policy Officer 60.0 1.07 X 412896 5639 83588 Donna McCullough Chief Development Officer 60.0 0.04 X 368439 215 64189 Scott Gardner Chief Chap. Relations Officer 60.0 0.0 X 349243 0 42256 Michael Carson Chief Marketing Officer 60.0 0.48 X 245433 1707 49240 Angela Geiger Chief Strategy Officer 0.0 0.0 X 101624 0 8985 3513917 9718 694732 122 true true false Hayworth Marketing Media LLC 45 South 7th Street Suite 2400 MINNEAPOLIS MN 55402 MEDIA 12430234 World-Wide Printing Distrib Inc 2900 E Apache TULSA OK 74110 Print/Letter Shop 5991944 Blackbaud Inc PO Box 930256 ATLANTA GA 311930256 Consultant 3114736 Webb Mason Inc PO Box 62414 BALTIMORE MD 212642414 Print/Letter Shop 3102726 Personify Inc PO Box 759470 BALTIMORE MD 212759470 SOFTWARE DEVELOPMENT 2771308 110 439669 2239597 22096172 278525353 5754565 303300791 PROGRAM CONFERENCES 611710 7714642 7714642 JOURNAL 511120 761546 761546 CAREGIVER TRAINING 611710 730115 730115 SAFE RETURN REGISTRATION FEES 611710 540673 540673 9746976 4803366 4803366 0 79252 79252 0 0 0 24580857 464098 23067315 601263 1513542 -137165 1376377 1376377 10324453 2239597 4600926 5723527 5723527 119702 118891 811 811 291736 97766 193970 177026 16944 LEGAL SETTLEMENT 900099 1860650 1860650 GROUP CHAPTER REVENUE 900099 352995 352995 AFFILIATE REVENUE 900099 20635 20635 2234280 327459350 9924002 14234557 26139264 26139264 3026030 3026030 3185042 3185042 0 2100007 1188746 614800 296461 0 127524625 96857642 6707113 23959870 17529047 13229653 976249 3323145 13298066 10100575 794123 2403368 365235 282470 26283 56482 0 2265610 1392311 583190 290109 379012 265583 62860 50569 2146576 2146576 1310457 1310457 255915 255915 21449556 15002635 1613376 4833545 22078908 19601681 235993 2241234 32056010 21334343 5001072 5720595 1531018 1124129 177706 229183 0 21540163 17010671 1625426 2904066 10355699 7514839 467273 2373587 0 14251357 9080014 203184 4968159 0 0 3793341 2607149 402082 784110 607094 376871 117648 112575 . 0 . 0 . 0 . 0 963730 619347 104394 239989 328151762 252341486 19712772 56097504 X 15483112 9333551 2401314 3748247 0 417659 38330322 57724862 38226245 54827463 13284637 10482245 0 0 0 0 266268 47468 879501 885536 4035909 8562543 39154237 21264745 9059732 17889492 71219128 160429873 21940244 32978937 0 0 0 0 0 843711 197241986 345089789 12932698 23502870 28986791 37213895 4223548 10150125 0 0 0 0 0 0 0 0 0 0 19268809 6356753 65411846 77223643 X 43597033 136430935 58852663 90231019 29380444 41204192 131830140 267866146 197241986 345089789 X -692412 5617742 131110676 X false true X true true true X 108426401 120142741 149251302 158669271 303300791 839790506 0 0 108426401 120142741 149251302 158669271 303300791 839790506 0 839790506 2376737 2089505 3055023 3039352 4882618 15443235 0 5918160 6103829 6633496 7077019 12716507 38449011 893682752 29530745 0.93970 0.93320 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED true true true 305341 true 1000 true true 1433291 true 2926141 true 3137579 false 7803352 false Schedule C, Part II-B, Line 1a Volunteers Most of the Association's advocacy is through volunteers. Additionally the association has training to develop and organize chapter based grassroots activities. As Alzheimer's disease and related dementias, hereafter referred to as Alzheimer's disease, threaten to bankrupt families, businesses and the healthcare system, scientists are moving closer to finding better treatments that could alter the course of the disease. The Alzheimer's Association advocates for public policies aimed at advancing research toward better therapies, detection, methods of prevention and ultimately a cure, as well as for high quality healthcare and long term services and support for people with Alzheimer's and their families. This includes advocacy for better care for people and families already facing Alzheimer's. Advocacy activities also include collaborating with other organizations to improve quality care and raise awareness of key issues. Schedule C, Part II-B, Line 1b Paid Staff or Management The Association has paid staff who engage on behalf of the Association in public policy work, including educating policymakers and supporting the advocacy work of volunteers. Schedule C, Part II-B, Line 1c MEDIA ADVERTISEMENTS Media advertisements were run in Washington, D.C. for key advocacy awareness opportunities during the year. Schedule C, Part II-B, Line 1d MAILING TO MEMBERS, LEGISLATORS OR THE PUBLIC Mailing costs to distribute Facts and Figures to legislators. Schedule C, Part II-B, Line 1e PUBLICATIONS, OR PUBLISHED OR BROADCAST STATEMENTS The Association distributed Federal and State Updates approximately 41 times during the year. Schedule C, Part II-B, Line 1f Grants to Other Organizations for Lobbying Purposes The Association makes a grant to AIM which is used for the lobbying purposes discussed above and which is also shown on the Form 990 of AIM as a lobbying expense. As such, the amount of the grant is reported twice for transparency purposes. Schedule C, Part II-B, Line 1g DIRECT CONTACT The Association uses internal staff and retained lobbyists to educate policymakers about the Association's policy recommendations. 13717133 10321498 1125281 1125281 24038631 13690883 26250 545968 545968 13717133 13715104 121524 537643 683388 13690883 12654952 1060152 1961725 1961725 13715104 11611486 333853 709613 12654952 0.97480 0.02520 false false 0 728500 728500 0 1750494 237446 1513048 0 7849848 4307390 3542458 0 8253014 6065306 2187708 0 20572381 10654603 9917778 17889492 BENEFICIAL INTEREST 32747656 F ASSETS HELD IN TRUST 231281 F 32978937 0 DUE TO CHAPTERS 1942872 GIFT ANNUITY OBLIGATIONS 4413881 6356753 X 340557641 5617742 5511513 1871270 13000525 327557116 -97766 -97766 327459350 335381192 5513778 1715652 7229430 328151762 328151762 SCHEDULE D, PART V, LINE 4 INTENDED USES OF ENDOWMENT FUNDS Permanently restricted net assets are restricted as investments in perpetuity. The Associations endowment only consists of donor-restricted endowment funds. Net assets associated with the Associations endowment funds are classified and reported based on the existence of donor-imposed restrictions. Donors restrict the earnings of some of the Associations endowment funds to fund the Associations research program. In accordance with donor stipulations, the income generated from these assets is restricted for research (approximately 57%) or not purpose restricted (approximately 43%). The Association accounts for endowment net assets by preserving the fair value of the original gift as of the gift date of the donor-restricted endowment fund absent explicit donor stipulations to the contrary. As a result, the Association classifies as permanently restricted net assets (1) the original value of gifts donated to the permanent endowment, (2) the original value of subsequent gifts to the permanent endowment and (3) accumulations to the permanent endowment made in accordance with the direction of the applicable donor gift instrument at the time the accumulation is added to the endowment fund. The Association considers the following factors in making a determination to appropriate or accumulate donor-restricted endowment funds: -The duration and preservation of the fund. -The purposes of the Association and the donor-restricted endowment fund. -General economic conditions. -The possible effects of inflation and deflation. -The expected total return from income and the appreciation of investments. -Other resources of the Association. -The investment policies of the Association. The Association has adopted an investment policy that attempts to provide a predictable stream of funding to programs supported by its endowment while seeking to maintain the purchasing power of the endowment assets. As of June 30, 2017, endowment assets only include those assets of donor-restricted funds that the Association must hold in perpetuity, as the Association does not have any board-designated endowment funds. Under this policy, as approved by the board of directors, the endowment assets are invested in a manner that is intended to provide adequate liquidity, maximizing returns on all funds invested and achieving full employment of all available funds as earning assets. The Association has an active finance committee and investment sub-committee that meets regularly to ensure that the objectives of the investment policy are met, and that the strategies used to meet the objectives are in accordance with the investment policy. The Association's policy is to appropriate spending amounts deemed prudent for donor-restricted funds. SCHEDULE D, PART X, LINE 2 FIN 48 THE ASSOCIATION AND ALZHEIMER'S IMPACT MOVEMENT (AIM) HAVE RECEIVED FAVORABLE DETERMINATION LETTERS FROM THE INTERNAL REVENUE SERVICE, STATING THAT THEY ARE EXEMPT FROM FEDERAL INCOME TAXES UNDER THE PROVISIONS OF SECTION 501(A) OF THE INTERNAL REVENUE CODE OF 1986 (IRC), AS ORGANIZATIONS DESCRIBED IN SECTIONS 501(C)(3) AND 501(C)(4), RESPECTIVELY, EXCEPT FOR INCOME TAXES PERTAINING TO UNRELATED BUSINESS INCOME. ALZHEIMER'S IMPACT MOVEMENT POLITICAL ACTION COMMITTEE (AIMPAC) IS A POLITICAL ACTION COMMITTEE ORGANIZATION EXEMPT FROM FEDERAL TAXES UNDER SECTION 527 OF THE IRC. THE ALZHEIMERS ASSOCIATION INTERNATIONAL IS A NOT-FOR-PROFIT CANADIAN ENTITY INCORPORATED ON JUNE 4, 2015. THE APPLICATION FOR CHARITABLE STATUS WAS APPROVED IN AUGUST 2017. THE FINANCIAL ACCOUNTING STANDARDS BOARD (FASB) ISSUED GUIDANCE THAT REQUIRES TAX EFFECTS FROM UNCERTAIN TAX POSITIONS TO BE RECOGNIZED IN THE CONSOLIDATED FINANCIAL STATEMENTS ONLY IF THE POSITION IS MORE LIKELY THAN NOT TO BE SUSTAINED IF THE POSITION WERE TO BE CHALLENGED BY A TAXING AUTHORITY. MANAGEMENT HAS DETERMINED THERE ARE NO MATERIAL UNCERTAIN POSITIONS THAT REQUIRE RECOGNITION IN THE CONSOLIDATED FINANCIAL STATEMENTS AND, AS SUCH, NO PROVISION FOR INCOME TAXES IS REFLECTED. ADDITIONALLY, THERE ARE NO INTEREST OR PENALTIES RECOGNIZED IN THE CONSOLIDATED STATEMENT OF ACTIVITIES OR STATEMENT OF FINANCIAL POSITION. Schedule D, Part XI, Line 2D RECONCILIATION OF REVENUE CHANGE IN PERPETUAL TRUST $1,492,475 CHANGE IN SPLIT INTEREST $378,795 ---------- TOTAL $1,871,270 SCHEDULE D, PART XI, LINE 4B RECONCILIATION OF REVENUE COST OF GOODS SOLD $(97,766) ---------- TOTAL $(97,766) SCHEDULE D, PART XII, LINE 2D RECONCILIATION OF EXPENSES COST OF GOODS SOLD $97,766 BAD DEBT EXPENSE $1,617,886 ---------- TOTAL $1,715,652 true Europe (Including Iceland and Greenland) Program Services Grantmaking 2243264 East Asia and the Pacific Program Services Grantmaking 520685 North America Program Services Grantmaking 421093 3185042 3185042 Europe (Including Iceland and Greenland) Program Support 150000 Check or WT FMV Europe (Including Iceland and Greenland) Program Support 174990 Check or WT FMV North America Program Support 69729 CHECK OR WT FMV East Asia and the Pacific Program Support 139735 CHECK OR WT FMV Europe (Including Iceland and Greenland) Program Support 123500 CHECK OR WT FMV East Asia and the Pacific Program Support 175000 CHECK OR WT FMV North America Program Support 175000 CHECK OR WT FMV Europe (Including Iceland and Greenland) Program Support 174999 CHECK OR WT FMV Europe (Including Iceland and Greenland) Program Support 173000 CHECK OR WT FMV Europe (Including Iceland and Greenland) Program Support 150000 CHECK OR WT FMV Europe (Including Iceland and Greenland) Program Support 150000 CHECK OR WT FMV East Asia and the Pacific Program Support 149700 CHECK OR WT FMV North America Program Support 81818 CHECK OR WT FMV Europe (Including Iceland and Greenland) Program Support 120000 CHECK OR WT FMV Europe (Including Iceland and Greenland) Program Support 150000 CHECK OR WT FMV Europe (Including Iceland and Greenland) Program Support 133800 CHECK OR WT FMV Europe (Including Iceland and Greenland) Program Support 450000 CHECK OR WT FMV Europe (Including Iceland and Greenland) Program Support 249975 CHECK OR WT FMV Europe (Including Iceland and Greenland) Program Support 43000 CHECK OR WT FMV East Asia and the Pacific Program Support 28125 CHECK OR WT FMV East Asia and the Pacific Program Support 28125 CHECK OR WT FMV North America Program Support 94546 CHECK OR WT FMV 22 false false true false false false Schedule F, Part I, Line 2 PROCEDURE FOR MONITORING USE OF GRANT FUNDS OUTSIDE U.S. The over-sight of the scientific integrity of the Alzheimer's Association National and International Research Grant Program is three-fold. First, the Alzheimer's Association voluntary Medical & Scientific Advisory Council along with the Alzheimer's Association Medical & Scientific Relations division, ensures peer review and high quality of funded awards during the grant review process and develops focused requests for applications (RFAs) based on identified needs in the Alzheimer research community. Second, the Alzheimer's Association is engaged in a portfolio analysis of scientific areas of investment to monitor the diversity of the grants portfolio, potential gaps in research funding, and potential overlap of areas funded. The analysis informs future funding decisions and areas of RFA focus. Third, there is a detailed process once a grant is awarded to monitor program and scientific and financial integrity. The Alzheimer's Association monitors the use of grant funds both inside and outside of the United States as follows: All awardees are required to provide annual and in some cases bi-annual reporting to the Alzheimer's Association on both the status of the research project and financial expenditures associated with the award. Several programs are leveraged funding opportunities with partner organizations. These research projects and financial expenditure reports are shared between the partner organization(s). Sixty days prior to the anniversary of the award, an Alzheimer's Association Post-Award Specialist notifies all researchers and all designated institutional financial officials with fiscal responsibility for the award of the required reports, which include an interim scientific report, and interim financial report and documentation of any publications as a result of Association funding. The institutional official who has fiscal responsibility for the award cannot be the primary investigator of the project. The Alzheimer's Association provides a template for the interim scientific report and a template for the interim financial report, both of which are available for download by the researchers as well as the official with fiscal responsibility for the grant at the awarded institution at https://proposalcentral.altum.com/login.asp. The financial report must be signed by the institutional official with fiscal responsibility, and all reports must be uploaded by the award recipient to Proposal Central. After receipt, all financial reports are reviewed by an Alzheimer's Association Post-Award Specialist for accuracy and consistency with the agreed upon budget. In addition, the Association requires protocol continuation approval (i.e., INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC), INSTITUTIONAL REVIEW BOARD (IRB), RECOMBINANT DNA PROTOCOL (RDNA)) annually, if applicable for the research project. Any subsequent payments to grant awardees are generated after the receipt and approval by the Chief Science Officer, Medical and Scientific Relations. At the conclusion of the award, all reports/publication(s) are due 90 days after the award expires and must be uploaded to Proposal Central online system. The financial report must be signed by the institutional official who has fiscal responsibility for the award. Publication(s) as accepted are uploaded to Proposal Central during and after the duration of the grant. It is expected that awardees will continue to maintain record of any publication(s) acknowledging the Alzheimer's Association. Data generated as a result of Alzheimer's Association funded work is subject to data sharing, as a condition of award. Data and other outputs of the project are subjected to this policy for quick, reasonable submissions for completed work. Further, Awardees agree to submit/share data, as applicable, through the Global Alzheimer's Association Interactive Network (GAAIN*), a global infrastructure connecting research studies from around the world through one portal where data can be interrogated in aggregate for analysis using a virtual machine. GAAIN is wholly funded by the Alzheimer's Association. In addition, the Association requests, monitors, and follows-up to ensure submission compliance on all awarded contracts and that financial reporting requirements are met. Awardees' financial reports are audited annually to ensure eligibility for continued funding. Delinquent report(s) may result in the withdrawal of funding. Researchers are informed that delinquent reporting could lead to withdrawal of funding when the request for annual report(s) is sent. If funding is withdrawn due to delinquent reports, any unspent funds must be returned to the Alzheimer's Association. This Researcher becomes ineligible to apply for funding from the Alzheimer's Association. Foreign Institutions are required to submit one of the following as verification of Non-Profit status: - Organization's charter, bylaws and other governing documents (In english, if possible). In cases where translation is not possible, a dated and signed letter in english from the rector or other authorized signing official of the institution is acceptable. - documentation of non-profit designation from organization's government. For-profit organizations are not eligible to apply to the Alzheimer's Association's International Research Grant Program, with the exception of the Part the Cloud Translational Research Grant Program AND PARTNERSHIP PROGRAMS SUCH AS BIOMARKERS ACROSS NEURODEGENERATIVE DISEASES(BAND). Unless otherwise stated in program, all institutions are required to submit verification of their non-profit status dated within the last five years (e.g., IRS tax determination letter). If the irs determination letter is dated prior to this five year period, the institution is required to provide documentation from an authorized SIGNING OFFICIAL IN THEIR GRANTS AND CONTRACTS OFFICE OR OFFICE OF SPONSORED RESEARCH to confirm there has not been a status change for the organization. For the Part the Cloud Translational Research Grant Program, any for-profit applicant is required to submit the Organization's financial statements. Prior to award confirmation, the Medical and Scientific Relations Division verifies that each awardee is compliant with the U.S. Patriot Act and does not appear on the Specially Designated Nationals (SDN) lists. A FORM IS COMPLETED FOR EACH APPROVED ALZHEIMER'S ASSOCIATION AWARDEE THAT VERIFIES COMPLIANCE WITH THE U.S. Patriot Act AND UPLOADED TO THEIR ONLINE FILE AT PROPOSAL CENTRAL PRIOR TO PAYMENT BEING SENT TO THE AWARDEE. IN THE EVENT THAT A POSITIVE MATCH TO ONE OF THE SDN LISTS IS FOUND BY THE ASSOCIATION, IT WOULD BE IMMEDIATELY REPORTED TO THE ALZHEIMER'S ASSOCIATION LEGAL DEPARTMENT FOR APPROPRIATE HANDLING AND FOLLOW-UP. For transactions unrelated to the International Research Grant Program in the Medical and Scientific Department, the same verification is performed. The Alzheimer's Association monitors the scientific advances of the Association's grant awardees by maintaining records of publications, presentations, and intellectual property that result from funded studies. The Association requires the grant recipient to notify the Alzheimer's Association on an annual basis with updates to these records. Follow-on funding from federal agencies is also monitored. * These are names that are trademarks to Alzheimer's Association X X X X X X X true THD 80 Hayden Avenue Ste 300 Lexington MA 02421 Mail&Email false 57681143 1310457 56370686 57681143 1310457 56370686 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY Hilarity - CA 1052150 108450 943700 74073 21892 274480 247335 NY Gala 1036800 40900 995900 130354 185999 197072 54 10475100 2090247 8384853 1633676 214839 1366024 175560 79622 12564050 2239597 10324453 1838103 236731 1826503 619967 79622 4600926 5723527 119702 811 118080 false 119702 811 118080 118891 811 IL IA NE true false true false Michelle Helton 225 N Michigan Ave 17th Flr Chicago IL 606017633 false Lynne Carey 600 Overall supervision and management X false Schedule G, Part I, Line 2B, Box (III) FUNDRAISING CONSULTANT - CONTROL ARRANGEMENT The Alzheimer's association engages Thompson, Habib & Denison INC. (THD) for professional fundraising consultant services. A description of the arrangement is listed below: Direct marketing strategy and program direction; production management; database management; e-mail program management; budgeting management; and report management. Schedule G, Part I, Line 2B, Box (VI) FUNDRAISING CONSULTANT - FEE ARRANGEMENT The agreement between Thompson, Habib & Denison (THD) and the Alzheimer's Association is not a percentage-based agreement. THD is paid a fixed fee per month. The Alzheimer's Association exercises control and approval over the content and frequency of all solicitations. Schedule G, Part III, Line 16 GAMING MANAGER INFORMATION Alzheimer's association has more gaming managers than lynne carey listed on part iii, line 16. This information is available upon request from alzheimer's home office. true Beth Israel Deaconness Medical Center 330 Brookline Avenue E/BR 264 Boston MA 02215 042103881 501(C)(3) 175000 Program Support The Brigham and Women's Hospital 75 Francis Street Boston MA 02115 104231290 501(C)(3) 139059 Program Support Massachusetts General Hospital Research Mgt 101 Huntington Ave Charlestown MA 02199 042697983 501(C)(3) 175000 Program Support New York University School of Medicine One Park Avenue 6th Floor New York NY 10016 135562308 501(C)(3) 175000 Program Support University of Florida 219 Grinter Hall Gainesville FL 32611 596002052 501(C)(3) 174961 Program Support University of Calif San Francisco 3333 California Street Suite 315 San Francisco CA 94118 946036493 501(C)(3) 175000 Program Support Oregon Health & Science Univ 3181 SW Sam Jackson Park Rd Portland OR 97239 931176109 501(C)(3) 174952 Program Support Emory University 1599 Clifton Road NE 4th Floor Atlanta GA 30322 580566256 501(C)(3) 170000 Program Support The University of Chicago 5801 South Ellis Avenue Chicago IL 60637 362177139 501(C)(3) 173000 Program Support Salk Institute for Biological Studies 10010 North Torrey Pines Road La Jolla CA 920371002 952160097 501(C)(3) 175000 Program Support Columbia University Medical Center 630 West 168th Street Box 49 New York NY 10032 135598093 501(C)(3) 175000 Program Support University of Southern California Department of Contracts and Grants Los Angeles CA 900891147 951642394 501(C)(3) 175000 Program Support University of Pittsburgh 123 University Place Pittsburgh PA 15213 250965591 501(C)(3) 175000 Program Support Cleveland Clinic Foundation 9500 Euclid Avenue Cleveland OH 44195 340714585 501(C)(3) 175000 Program Support Columbia University 630 West 168th Street New York NY 100323702 135598093 501(C)(3) 140000 Program Support Brigham and Women's Hospital Inc 75 Francis Street Boston MA 02115 104231290 501(C)(3) 175000 Program Support Univ of Texas Health at San Antonio 7703 Floyd Curl Drive San Antonio TX 782293900 741586031 501(C)(3) 140000 Program Support Yale University PO Box 208327 New Haven CT 065208327 060646973 501(C)(3) 174984 Program Support University of California San Diego 9500 Gilman Drive San Diego CA 92093 956006144 501(C)(3) 175000 Program Support University of Pennsylvania 3451 Walnut Street P-221 Philadelphia PA 19104 231352685 501(C)(3) 168625 Program Support Univ of Calif Lawrence Berkeley Lab 1 Cyclotron Road Berkeley CA 94720 942951741 501(C)(3) 174973 Program Support Icahn School of Medicine One Gustave L Levy PL Box 1075 New York NY 10029 136171197 501(C)(3) 174981 Program Support J David Gladstone Institutes 1650 Owens Street San Francisco CA 94158 123720366 501(C)(3) 175000 Program Support Yale University PO Box 208327 New Haven CT 06520 060646973 501(C)(3) 174947 Program Support University of South Florida 3702 Spectrum Blvd Suite 165 Tampa FL 33612 593102112 501(C)(3) 140000 Program Support Baylor College of Medicine One Baylor Plaza Houston TX 77030 741613878 501(C)(3) 174970 Program Support Columbia University Medical Center Sponsored Projects Administrationr New York NY 10032 135598093 501(C)(3) 174999 Program Support University of North Dakota 264 Centennial Drive Grand Forks ND 58202 456002491 501(C)(3) 175000 Program Support University of California San Diego 9500 Gilman Drive San Diego CA 92093 966006144 501(C)(3) 175000 Program Support Boston University 75 East Newton St Boston MA 02118 104210354 501(C)(3) 171920 Program Support University of Wisconsin Madison 21 North Park St Madison WI 53715 396006492 501(C)(3) 173174 Program Support Baylor College of Medicine One Baylor Plaza Houston TX 77030 741613878 501(C)(3) 140000 Program Support Columbia University Medical Center 630 West 168th Street Box 49 New York NY 10032 135598093 501(C)(3) 140000 Program Support The University of Texas at San Antonio One UTSA Circle San Antonio TX 78249 741717115 501(C)(3) 175000 Program Support New York University School of Medicine One Park Avenue New York NY 10016 135562308 501(C)(3) 175000 Program Support East Carolina University 2200 Charles Blvd Greenville NC 27858 566000400 501(C)(3) 140000 Program Support University of IL at Champaign 1901 S First St Champaign IL 61820 376000511 501(C)(3) 136915 Program Support University of Wisconsin-Madison 21 North Park Street Suite 6401 Madison WI 53715 396006492 501(C)(3) 150000 Program Support Case Western Reserve University 10900 Euclid Avenue Cleveland OH 441064919 341018992 501(C)(3) 150000 Program Support Mayo Clinic Jacksonville 4500 San Pablo Road Jacksonville FL 32224 159337028 501(C)(3) 150000 Program Support University of California San Diego 9500 Gilman Drive Dept 0934 San Diego CA 920930934 956006144 501(C)(3) 149995 Program Support University of Utah 75 S 2000 E Rm 111 Salt Lake City UT 84112 876000525 501(C)(3) 149998 Program Support Arizona State University PO Box 2260 Tempe AZ 852802260 866051042 501(C)(3) 149997 Program Support Old Dominion University 4111 Monarch Way Suite 204 Norfolk VA 235082561 546068198 501(C)(3) 150000 Program Support Columbia University Medical Center 630 West 168th Street Box 49 New York NY 10032 135598093 501(C)(3) 150000 Program Support The Regents of the University of CA (Irvine) 141 Innovation Suite 250 Irvine CA 926977600 952226406 501(C)(3) 150000 Program Support University of Calif Los Angeles 10889 Wilshire Blvd Suite 700 Los Angeles CA 90095 956006143 501(C)(3) 150000 Program Support Massachusetts General Hospital 55 Fruit Street Boston MA 02114 042697983 501(C)(3) 150000 Program Support Beth Israel Deaconess Medical Center 330 Brookline Ave Boston MA 02215 042103881 501(C)(3) 150000 Program Support Brigham and Women's Hospital Inc 75 Francis Street Boston MA 02115 104231290 501(C)(3) 149913 Program Support Washington University in StLouis One Brookings Drive St Louis MO 63130 430653611 501(C)(3) 150000 Program Support Mayo Clinic 200 First St SW Rochester MN 55905 416011702 501(C)(3) 149998 Program Support Florida Atlantic University 777 Glades Road Boca Raton FL 33431 650385507 501(C)(3) 149467 Program Support University of New Mexico 1700 Lomas BLvd NE Ste 2200 Albuquerque NM 87131 856000642 501(C)(3) 150000 Program Support Northwestern University - Evanston 1801 Maple Ave Suite 2410 Evanston IL 60201 362167817 501(C)(3) 150000 Program Support University of California (Irvine) 141 Innovation Suite 250 Irvine CA 92697 952226406 501(C)(3) 150000 Program Support Washington University in StLouis One Brookings Drive St Louis MO 63130 430653611 501(C)(3) 150000 Program Support University of Maryland Baltimore 1000 Hilltop Circle Baltimore MD 21250 526002033 501(C)(3) 150000 Program Support The Brigham and Women's Hospital Inc 75 Francis Street Boston MA 02115 104231290 501(C)(3) 150000 Program Support Cornell University 1300 York Avenue Box 89 New York NY 10065 131623978 501(C)(3) 150000 Program Support Tufts Medical Center 800 Washington Street Boston MA 02111 043400617 501(C)(3) 150000 Program Support New York University One Park Avenue New York NY 10016 135562308 501(C)(3) 150000 Program Support University of TX at Galveston 301 University Blvd Galveston TX 77555 740000949 501(C)(3) 150000 Program Support Mayo Clinic Jacksonville 4500 San Pablo Road Jacksonville FL 32224 159337028 501(C)(3) 150000 Program Support Boston University 85 East Newton Street Boston MA 02119 104210354 501(C)(3) 149415 Program Support New York University One Park Avenue New York NY 10016 135562308 501(C)(3) 150000 Program Support Wm Beaumont Hospital 3811 W Thirteen Mile Rd Royal Oak MI 48072 381459362 501(C)(3) 149451 Program Support Columbia University 630 West 168th St New York NY 10032 135598093 501(C)(3) 149999 Program Support Oregon Health & Science University 3181 SW Sam Jackson Portland OR 97239 931176109 501(C)(3) 146784 Program Support University of Pittsburgh 123 University Place Pittsburgh PA 15213 250965591 501(C)(3) 149386 Program Support MN Veterans Medical Res & Education Fdn 1 Veterans Drive Minneapolis MN 55417 411652941 501(C)(3) 150000 Program Support Baylor College of Medicine One Baylor Plaza Houston TX 77030 741613878 501(C)(3) 150000 Program Support Arizona State University Foundation PO Box 2260 Tempe AZ 85280 866051042 501(C)(3) 150000 Program Support Iowa State University of Science and Technology 1138 Pearson Hall Ames IA 50011 426004224 501(C)(3) 149820 Program Support Trinity University One Trinity Place San Antonio TX 78212 741109633 501(C)(3) 150000 Program Support University of Miami 1320 S Dixie Highway Coral Gables FL 33146 560624458 501(C)(3) 120000 Program Support UCLA 10889 Wilshire Blvd Los Angeles CA 90095 956006143 501(C)(3) 149881 Program Support Vanderbilt 2301 Vanderbilt Place Nashville TN 37240 620476822 501(C)(3) 150000 Program Support Rush University Medical Center 1653 W Congress Parkway Chicago IL 60612 362174823 501(C)(3) 449955 Program Support New York University School of Medicine Sponsored Programs Administration O New York NY 10016 135562308 501(C)(3) 444225 Program Support Indiana University (Indianapolis) Indiana University Office of Resear Indianapolis IN 462022915 356001673 501(C)(3) 450000 Program Support University of CA San Diego-Health Science 9500 Gilman Drive Mail Code 0041 San Diego CA 92093 956006144 501(C)(3) 700000 Program Support Neurophage Pharmaceuticals Inc 222 Third Street Suite 3120 Cambridge MA 02142 208558071 N/A 700000 Program Support NeuroTherapia Inc 10000 Cedar Ave Cleveland OH 44040 473977513 N/A 700000 Program Support University of Kentucky Research Foundation 109 Kinkead Hall Lexington KY 40506 616033693 501(C)(3) 997738 Program Support Stanford University Research Management Group 3172 Port Palo Alto CA 94304 941156365 501(C)(3) 250000 Program Support Texas Tech University Health Sciences Centr 3601 4th St MS 6271 Lubbock TX 79430 752668014 501(C)(3) 249999 Program Support University of Wisconsin-Milwaukee PO Box 340 Milwaukee WI 53201 391805963 501(C)(3) 250000 Program Support University of Colorado Denver 500 13001 E 17th Place W1126 Aurora CO 80045 846000555 501(C)(3) 199714 Program Support USCUniversity of Southern California 3720 S Flower Street Los Angeles CA 90089 951642394 501(C)(3) 249879 Program Support USCUniversity of Southern California 3720 S Flower Street Los Angeles CA 90089 951642394 501(C)(3) 249279 Program Support Washington University in StLouis One Brookings Drive St Louis MO 631304862 430653611 501(C)(3) 249999 Program Support USCUniversity of Southern California 3720 S Flower Street Los Angeles CA 90089 951642394 501(C)(3) 249990 Program Support Massachusetts Gen Hospital 101 Huntington Avenue Boston MA 02199 042697983 501(C)(3) 96249 Program Support Foundation for the NIH 9650 Rockfille Pike Bethesda MD 20814 521986675 501(C)(3) 200000 Program Support Massachusetts Gen Hospital 101 Huntington Avenue Boston MA 02199 042697983 501(C)(3) 96250 Program Support University of Southern Calif 3720 Flower Street Los Angeles CA 90089 951642394 501(C)(3) 871541 Program Support Indiana University 410 West 10th Street Indianapolis IN 46202 356001673 501(C)(3) 449400 Program Support Foundation for the NIH 9650 Rockfille Pike Bethesda MD 20814 521986675 501(C)(3) 298830 Program Support American College of Radiology 1891 Preston White Drive Reston VA 20191 362261602 501(C)(3) 200000 Program Support University of Southern Calif 3720 Flower Street Los Angeles CA 90089 951642394 501(C)(3) 457000 Program Support Washington University St Louis 660 South Euclid Ave St Louis MO 63110 143065361 501(C)(3) 664598 Program Support Washington University St Louis 660 South Euclid Ave St Louis MO 63110 143065361 501(C)(3) 106453 Program Support Banner ALZ Foundation 2901 N Central Avenue Phoenix AZ 85012 204862361 501(C)(3) 750000 Program Support University of Southern Calif 3720 Flower Street Los Angeles CA 90089 951642394 501(C)(3) 871541 Program Support University of Southern Calif 3720 Flower Street Los Angeles CA 90089 951642394 501(C)(3) 457000 Program Support University of Pennsylvania 3451 Walnut St Philadelphia PA 19104 231352685 501(C)(3) 50000 Program Support NCCHR 101 Connecticut Ave NW 632 Washington DC 20036 521122531 509a 93429 Program Support ALZHEIMERS IMPACT MOVEMENT 225 North Michigan Avenue Chicago IL 60601 271961435 501(C)(4) 1433291 Public Policy 105 4 Schedule I, Part I, Line 2 PROCEDURE FOR MONITORING USE OF GRANT FUNDS INSIDE U.S. The over-sight of the scientific integrity of the Alzheimer's Association National and International Research Grant Program is three-fold. First, the Alzheimer's Association voluntary Medical & Scientific Advisory Council along with the Alzheimer's Association Medical & Scientific Relations division, ensures peer review and high quality of funded awards during the grant review process and develops focused requests for applications (RFAs) based on identified needs in the Alzheimer research community. Second, the Alzheimer's Association is engaged in a portfolio analysis of scientific areas of investment to monitor the diversity of the grants portfolio, potential gaps in research funding, and potential overlap of areas funded. The analysis informs future funding decisions and areas of RFA focus. Third, there is a detailed process once a grant is awarded to monitor program and scientific and financial integrity. The Alzheimer's Association monitors the use of grant funds both inside and outside of the United States as follows: All awardees are required to provide annual and in some cases bi-annual reporting to the Alzheimer's Association on both the status of the research project and financial expenditures associated with the award. Several programs are leveraged funding opportunities with partner organizations. These research projects and financial expenditure reports are shared between the partner organization(s). Sixty days prior to the anniversary of the award, an Alzheimer's Association Post-Award Specialist notifies all researchers and all designated institutional financial officials with fiscal responsibility for the award of the required reports, which include an interim scientific report, and interim financial report and documentation of any publications as a result of Association funding. The institutional official who has fiscal responsibility for the award cannot be the primary investigator of the project. The Alzheimer's Association provides a template for the interim scientific report and a template for the interim financial report, both of which are available for download by the researchers as well as the official with fiscal responsibility for the grant at the awarded institution at https://proposalcentral.altum.com/login.asp. The financial report must be signed by the institutional official with fiscal responsibility, and all reports must be uploaded by the award recipient to Proposal Central. After receipt, all financial reports are reviewed by an Alzheimer's Association Post-Award Specialist for accuracy and consistency with the agreed upon budget. In addition, the Association requires protocol continuation approval (i.e., INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC), INSTITUTIONAL REVIEW BOARD (IRB), RECOMBINANT DNA PROTOCAL (RDNA)) annually, if applicable for the research project. Any subsequent payments to grant awardees are generated after the receipt and approval by the Chief Science Officer, Medical and Scientific Relations. At the conclusion of the award, all reports/publication(s) are due 90 days after the award expires and must be uploaded to Proposal Central online system. The financial report must be signed by the institutional official who has fiscal responsibility for the award. Publication(s) as accepted are uploaded to Proposal Central during and after the duration of the grant. It is expected that awardees will continue to maintain record of any publication(s) acknowledging the Alzheimer's Association. Data generated as a result of Alzheimer's Association funded work is subject to data sharing, as a condition of award. Data and other outputs of the project are subjected to this policy for quick, reasonable submissions for completed work. Further, Awardees agree to submit/share data, as applicable, through the Global Alzheimer's Association Interactive Network (GAAIN*), a global infrastructure connecting research studies from around the world through one portal where data can be interrogated in aggregate for analysis using a virtual machine. GAAIN is wholly funded by the Alzheimer's Association. In addition, the Association requests, monitors, and follows-up to ensure submission compliance on all awarded contracts and that financial reporting requirements are met. Awardees' financial reports are audited annually to ensure eligibility for continued funding. Delinquent report(s) may result in the withdrawal of funding. Researchers are informed that delinquent reporting could lead to withdrawal of funding when the request for annual report(s) is sent. If funding is withdrawn due to delinquent reports, any unspent funds must be returned to the Alzheimer's Association. This Researcher becomes ineligible to apply for funding from the Alzheimer's Association. For-profit organizations are not eligible to apply to the Alzheimer's Association's International Research Grant Program, with the exception of the Part the Cloud Translational Research Grant Program AND PARTNERSHIP PROGRAMS SUCH AS BIOMARKERS ACROSS NEURODEGENERATIVE DISEASES (BAND). Unless otherwise stated in program, all institutions are required to submit verification of their non-profit status dated within the last five years (e.g., IRS tax determination letter). If the irs determination letter is dated prior to this five year period, the institution is required to provide documentation from an authorized SIGNING OFFICIAL IN THEIR GRANTS AND CONTRACTS OFFICE OR OFFICE OF SPONSORED RESEARCH to confirm there has not been a status change for the organization. For the Part the Cloud Translational Research Grant Program, any for-profit applicant is required to submit the Organization's financial statements. Prior to award confirmation, the Medical and Scientific Relations Division verifies that each awardee is compliant with the U.S. Patriot Act and does not appear on the Specially Designated Nationals (SDN) lists. A FORM IS COMPLETED FOR EACH APPROVED ALZHEIMER'S ASSOCIATION AWARDEE THAT VERIFIES COMPLIANCE WITH THE U.S. Patriot Act AND UPLOADED TO THEIR ONLINE FILE AT PROPOSAL CENTRAL PRIOR TO PAYMENT BEING SENT TO THE AWARDEE. IN THE EVENT THAT A POSITIVE MATCH TO ONE OF THE SDN LISTS IS FOUND BY THE ASSOCIATION, IT WOULD BE IMMEDIATELY REPORTED TO THE ALZHEIMER'S ASSOCIATION LEGAL DEPARTMENT FOR APPROPRIATE HANDLING AND FOLLOW-UP. For transactions unrelated to the International Research Grant Program in the Medical and Scientific Department, the same verification is performed. The Alzheimer's Association monitors the scientific advances of the Association's grant awardees by maintaining records of publications, presentations, and intellectual property that result from funded studies. The Association requires the grant recipient to notify the Alzheimer's Association on an annual basis with updates to these records. Follow-on funding from federal agencies is also monitored. The Alzheimer's Association granted funds to Alzheimer's Impact Movement (AIM) for public policy division activities in fiscal year 2017 to support priorities identified in the Alzheimer's Association's strategic plan. This grant is restricted to the following 501(c)3 activities and the ancillary activities necessary to accomplish specific goals including: Implementation of the National Alzheimer's Project Act (Recognizing this growing Alzheimer's crisis, Congress unanimously passed and the President signed into law the National Alzheimer's Project Act - NAPA); increasing the commitment to Alzheimer's research; expanding education efforts and caregiver support services; expanding diagnosis and planning. * These are names that are trademarks to Alzheimer's Association X true true X X X X X false true false false false false false false false HARRY JOHNS President & CEO 711496 1539 144134 0 1216 0 229150 0 21923 0 1107919 1539 0 0 RICHARD HOVLAND COO/CFO 383121 522 131250 0 2104 0 66650 0 31664 0 614789 522 0 0 Maria Carrillo Chief Science Officer 324756 0 95400 0 458 0 54150 0 5105 0 479869 0 0 0 Robert Egge Chief Public Policy Officer 317029 5639 95400 0 467 0 52315 0 31273 0 496484 5639 0 0 Donna McCullough Chief Development Officer 297778 215 69427 0 1234 0 54150 0 10039 0 432628 215 0 0 Scott Gardner Chief Chap. Relations Officer 266277 0 81210 0 1756 0 29150 0 13106 0 391499 0 0 0 Michael Carson Chief Marketing Officer 212979 1707 32250 0 204 0 21440 0 27800 0 294673 1707 0 0 Christine Foh Asst Secy & VP Legal & GC 199627 96 40615 0 2105 0 26937 0 10895 0 280179 96 0 0 Angela Geiger Chief Strategy Officer 82966 0 0 0 18658 0 6688 0 2297 0 110609 0 0 0 SCHEDULE J, PART I, LINE 1A TRAVEL FOR COMPANIONS At times a board member with early onset Alzheimers disease may require a companion to accompany him or her on business travel for safety reasons. Since his or her involvement in the meetings is critical to representing key constituents and appropriately fulfilling the mission of the Alzheimers association, the expenses of companion travel are reimbursed. SCHEDULE J, PART I, LINE 4B SUPPLEMENTAL NON-QUALIFIED RETIREMENT PLAN Harry Johns participates in a 457(f) supplemental non-qualified deferred compensation or retirement plan. The accrual amount under the plan in calendar year 2016 was $150,000. The accrual is part of a multi-year benefit which will become vested in 2017. There were no additional amounts accrued or reported for Harry Johns, Angela Geiger, or Richard Hovland related to a 457(b) plan in calendar year 2016. Schedule J, Part II, Column (b)(ii) Supplemental Compensation Information Harry johns received performance based incentive compensation of $144,134 based on his successful achievement of specific goals, which were developed, reviewed, and approved by the compensation committee of the board of directors in consultation with the board's independent third-party compensation consultants. This performance based incentive compensation was earned for performance in fiscal year 2016 and was paid in calendar year 2016. Schedule J, Part II, Column (b)(iii) Supplemental Compensation Information: Other Reportable Compensation Harry Johns, Angela Geiger, and Richard Hovland all receive a basic life insurance benefit of one times the annual salary. The amount represented in this section is imputed income for the group term life benefit. Robert Egge, Maria Carrillo, Donna McCullough, Scott Gardner, Michael Carson, and Christine Foh also receive the life insurance benefit. Richard Hovland, Donna McCullough, and Christine Foh have additional imputed income for voluntary elections under the group disability plan. Schedule J, Part II, Column (c) Supplemental Compensation Information Harry Johns - retirement and other deferred compensation of $179,150 is comprised of the following: -Employer contributions to the qualified broad-based 401(k) retirement plan - $29,150; -Employer accrual of retirement benefit to a supplemental retirement account under the previously discussed 457(f) - $150,000 -Retention incentive accrual which was not paid as of December 31, 2016, but which is tied to multi-year vesting through June 30, 2017 payable November 1, 2017. Richard Hovland - Retirement and other deferred compensation include employer contribution to a qualified 401(k) plan and a retention incentive accrual which was not paid as of December 31, 2016, but which is tied to specific multi-year vesting requirements through June 30, 2018. Robert Egge, Maria Carrillo, and Donna McCullough - Retirement and other deferred compensation include employer contribution to a qualified 401(k) plan and a retention incentive accrual which was not paid as of December 31, 2016, but which is tied to specific multi-year vesting requirements through June 30, 2018 for Robert Egge and Maria Carrillo; 2020 for Donna McCullough. Scott Gardner, Michael Carson, and Christine Foh - Retirement and other deferred compensation include employer contributions to a qualified 401(k) plan. Schedule J, Part II, Column (d) Supplemental Compensation Information Harry Johns - Non-taxable benefits of $21,923 include employer contributions to medical, dental, basic life insurance, short and long-term disability, and long term care insurance based on his personal elections for calendar year 2016 through the benefit offerings available to all other benefits-eligible employees at our organization. The amounts represented for Richard Hovland, Angela Geiger, Robert Egge, Maria Carrillo, Donna McCullough, Scott Gardner, Michael Carson and Christine Foh represent company contributions to the medical, dental, basic life insurance, short and long term disability, and long term care insurances based on individual elections. TANDEM SOLUTIONS FORMER BOARD MEMBER 232941 INDEPENDENT CONTRACTOR false Schedule L, Part IV Description of Business Transactions Involving Interested Persons Joseph McCafferty, former board member of Alzheimers Association, resigned on July 7th, 2016. Following his resignation, Mr. McCafferty's company, tandem solutions, was engaged as an independent contractor. X 310 3704317 FAIR MARKET VALUE X GALA-RELATED NONCASH ITEMS 2152 864306 FAIR MARKET VALUE X NON GALA-RELATED NONCASH ITEMS 520 539985 FAIR MARKET VALUE X FUNDRAISING NONCASH ITEMS 647 463811 FAIR MARKET VALUE X RAFFLE NONCASH ITEMS 818 118080 FAIR MARKET VALUE X MISC NONCASH ITEMS 51 64066 FAIR MARKET VALUE 0 false true true SCHEDULE M, PART I, LINE 25 AND LINE 32B THIRD PARTY ASSISTANCE OF NONCASH CONTRIBUTIONS LINE 25 - THE ALZHEIMER'S ASSOCIATION RECEIVES VARIOUS NONCASH CONTRIBUTIONS FOR THEIR FUNDRAISING EVENTS. THESE ITEMS INCLUDE SPORTING TICKETS, JEWELRY, CONCERT TICKETS, DINNERS AND VARIOUS OTHER PACKAGES. LINE 32B: A THIRD PARTY RECEIVES DIRECTLY, SELLS AND REMITS PROCEEDS FROM AUTOMOBILE SALES. Schedule M, Part I, Column B Alzheimer's Association is reporting the dollar amount of noncash contributions as well as the number of items received. Form 990, Part III, Line 1 Organization's Mission, continued THE MISSION OF THE ALZHEIMER'S ASSOCIATION IS TO ELIMINATE ALZHEIMER'S DISEASE THROUGH THE ADVANCEMENT OF RESEARCH; TO PROVIDE AND ENHANCE CARE AND SUPPORT FOR ALL AFFECTED; AND TO REDUCE THE RISK OF DEMENTIA THROUGH THE PROMOTION OF BRAIN HEALTH. THE VISION OF THE ALZHEIMER'S ASSOCIATION IS A WORLD WITHOUT ALZHEIMER'S. THE ALZHEIMER'S ASSOCIATION IS A VALUED RESOURCE FOR CAREGIVERS AND THOSE LIVING WITH THE DISEASE, OFFERING INFORMATION, EDUCATION AND SUPPORT. THE ALZHEIMER'S ASSOCIATION HAS 81 CHAPTERS WORKING TOGETHER TO ACCOMPLISH THE MISSION. THE ORGANIZATION IS HEADQUARTERED IN CHICAGO, AND HAS A PUBLIC POLICY OFFICE IN WASHINGTON, D.C. THE ALZHEIMER'S ASSOCIATION PROVIDES 24/7 CONSTITUENT SUPPORT IN OVER 170 LANGUAGES THROUGH THE USE OF A PROFESSIONAL LANGUAGE LINE 365 DAYS A YEAR (1-800-272-3900) AS WELL AS ON OUR WEBSITE, ALZ.ORG. AS THE LEADING VOLUNTARY HEALTH ORGANIZATION IN CARE, SUPPORT AND RESEARCH, SINCE AWARDING THE FIRST GRANTS IN 1982, THE ASSOCIATION HAS COMMITTED MORE THAN $375 MILLION TO MORE THAN 2,400 BEST-OF-FIELD GRANTS. AS A LEADER IN THE FIELD, THE ALZHEIMER'S ASSOCIATION FOSTERS COLLABORATION OF THE SCIENTIFIC COMMUNITY BY HOSTING THE LARGEST INTERNATIONAL CONFERENCE FOCUSING ON ALZHEIMER'S DISEASE RESEARCH IN THE WORLD. IN ADDITION, THE ALZHEIMER'S ASSOCIATION ADVOCATES FOR THE NEEDS AND RIGHTS OF PEOPLE WITH ALZHEIMER'S, THEIR FAMILIES AND CAREGIVERS, SPEAKING UP TO HELP ENCOURAGE CONGRESS TO TAKE ACTION IN THE FIGHT AGAINST THIS DISEASE, (INCLUDING THROUGH AN ANNUAL ADVOCACY FORUM IN WASHINGTON, D.C.) AND LEADS ADVOCACY EFFORTS IN EVERY STATE. CONCERN ABOUT ALZHEIMER'S DISEASE AND AWARENESS ABOUT THE ASSOCIATION ARE CRITICAL TO ACCELERATING PROGRESS. THE ALZHEIMER'S ASSOCIATION STRIVES TO MAKE MORE PEOPLE AWARE OF THE SERVICES AVAILABLE FOR THOSE FACING THIS DISEASE AND THE BENEFITS OF EARLY DETECTION. (MORE THAN 5 MILLION ALZHEIMER'S ASSOCIATION CONSTITUENTS HAVE SIGNED UP TO EDUCATE, ADVOCATE, DONATE, AND PARTICIPATE TO MOVE THIS CAUSE FORWARD). A DONOR-SUPPORTED ORGANIZATION, THE ALZHEIMER'S ASSOCIATION ALLOCATES ITS FUNDS IN AN ETHICAL AND RESPONSIBLE MANNER THAT EXCEEDS THE RIGOROUS STANDARDS OF AMERICA'S MOST EXPERIENCED CHARITY EVALUATOR, THE BETTER BUSINESS BUREAU WISE GIVING ALLIANCE. THE ASSOCIATION IS QUALIFIED TO USE THE "BBB TORCH LOGOA NATIONAL CHARITY SEAL ("SEAL"). Form 990, Part III, Line 4d OTHER PROGRAM SERVICES ADVOCACY - AS ALZHEIMER'S DISEASE THREATENS TO BANKRUPT FAMILIES, BUSINESSES AND OUR HEALTHCARE SYSTEM, SCIENTISTS ARE MOVING CLOSER TO FINDING BETTER TREATMENTS THAT COULD ALTER THE COURSE OF THE DISEASE. THE ALZHEIMER'S ASSOCIATION ADVOCATES FOR PUBLIC POLICIES AIMED AT ADVANCING RESEARCH TOWARD BETTER THERAPIES, DETECTION, METHODS OF PREVENTION AND ULTIMATELY A CURE, AS WELL AS FOR BETTER CARE AND RESOURCES, AND HEALTH AND LONG-TERM COVERAGE TO ENSURE HIGH QUALITY COST EFFECTIVE CARE FOR PEOPLE WITH ALZHEIMER'S DISEASE AND THEIR FAMILIES. MORE THAN 600,000 GRASS ROOTS ALZHEIMER'S ASSOCIATION ADVOCATES SPEAK UP FOR THE NEEDS AND RIGHTS OF PEOPLE WITH ALZHEIMER'S AND THEIR FAMILIES, AND ENCOURAGE CONGRESS TO INCREASE FUNDING FOR RESEARCH AND CARE. ADVOCACY ACTIVITIES ALSO INCLUDE COLLABORATING WITH OTHER ORGANIZATIONS TO IMPROVE QUALITY CARE AND RAISE AWARENESS OF KEY ISSUES. PATIENT AND FAMILY SERVICES - THE ALZHEIMER'S ASSOCIATION* PROVIDES AN ARRAY OF INFORMATION AND SUPPORT SERVICES DESIGNED SPECIFICALLY FOR INDIVIDUALS WITH ALZHEIMER'S DISEASE, THEIR FAMILIES, FRIENDS AND CAREGIVERS. IN ORDER TO MEET THE DIVERSE NEEDS OF INDIVIDUALS AFFECTED BY ALZHEIMER'S DISEASE, THE ASSOCIATION'S PROGRAMS AND SERVICES ARE OFFERED IN PERSON, BY PHONE AND ONLINE. IN CHAPTERS THROUGHOUT THE COUNTRY, CONSTITUENTS CAN ATTEND EDUCATION PROGRAMS AND SUPPORT GROUPS, RECEIVE PERSONALIZED CARE CONSULTATION, ENGAGE IN EARLY STAGE PROGRAMS, ENROLL IN SUPPORT PROGRAMS AND PURCHASE PRODUCTS TO REDUCE THE RISKS ASSOCIATED WITH WANDERING. IN ORDER TO MEET THE NEEDS OF CONSTITUENTS WHO RELY ON THE WEB FOR INFORMATION AND SUPPORT, THE ASSOCIATION OFFERS A ROBUST CAREGIVER CENTER. WITHIN THE CAREGIVER CENTER, FAMILIES AND CAREGIVERS CAN ACCESS ALZHEIMER'S NAVIGATOR*, AN INNOVATIVE TOOL TO HELP CAREGIVERS AND PEOPLE WITH DEMENTIA EVALUATE THEIR NEEDS, CREATE A CUSTOMIZED ACTION PLAN AND LINK TO INFORMATION, SUPPORT AND LOCAL RESOURCES FOR INDIVIDUALS LIVING WITH ALZHEIMER'S. ALSO AVAILABLE THROUGH THE CAREGIVER CENTER, FOR INDIVIDUALS LOOKING FOR SUPPORT FROM OTHERS LIVING IN SIMILAR SITUATIONS IS ALZCONNECTED*, AN ON-LINE COMMUNITY THAT INCLUDES MULTIPLE FORUMS FOR DIVERSE AUDIENCES. THROUGH THE ASSOCIATION'S HELPLINE, AVAILABLE 24 HOURS A DAY, 7 DAYS A WEEK, 365 DAYS A YEAR, INDIVIDUALS WITH ALZHEIMER'S DISEASE, THEIR FAMILIES AND CAREGIVERS CAN TALK TO A SPECIALIST TO RECEIVE INFORMATION AND BASIC EDUCATION ABOUT THE DISEASE; AND GUIDANCE FOR MORE COMPLICATED OR URGENT SITUATIONS, WITH MASTERS-LEVEL COUNSELORS WHO ARE AVAILABLE TO CONSTITUENTS, ANY TIME, DAY OR NIGHT. ADDITIONALLY, CALLS CAN BE HANDLED IN OVER 170 DIFFERENT LANGUAGES THROUGH THE USE OF A PROFESSIONAL LANGUAGE LINE. ANNUALLY, THE HELPLINE RECEIVES MORE THAN 300,000 CALLS. THE ASSOCIATION'S WEBSITE (WWW.ALZ.ORG) RECEIVES more than 41 million visits a year. ONLINE PROGRAMS INCLUDE: SELF-SERVICE EDUCATION PROGRAMS, AN ONLINE COMMUNITY, AN INTERACTIVE BRAIN TOUR (AVAILABLE IN 15 LANGUAGES), ACCESS TO COMPREHENSIVE DISEASE INFORMATION, PORTALS IN SPANISH, CHINESE, VIETNAMESE, JAPANESE, AND KOREAN; A VIRTUAL LIBRARY, A SAFETY CENTER, AND A SECTION DEVELOPED SPECIFICALLY FOR PEOPLE LIVING WITH ALZHEIMER'S, WITH INPUT FROM PEOPLE IN THE EARLY STAGES OF ALZHEIMER'S DISEASE AND THEIR CARE PARTNERS. THROUGH THE ASSOCIATION'S EARLY STAGE INITIATIVE, INDIVIDUALS IN THE EARLY STAGES OF THE DISEASE CAN PARTICIPATE IN EDUCATION PROGRAMS, SUPPORT GROUPS AND SOCIAL ENGAGEMENT PROGRAMS. ADDITIONALLY, THE ASSOCIATION CONVENES AN EARLY STAGE ADVISORY GROUP WHOSE MEMBERS RAISE AWARENESS, ADVOCATE FOR THE CAUSE, AND PROVIDE GUIDANCE AND REVIEW OF PROGRAMS AND SERVICES. THE PROGRAMS AND SERVICES OF THE ALZHEIMER'S ASSOCIATION ARE DESIGNED TO PROVIDE EDUCATION, INFORMATION, SUPPORT, AND RESOURCES IN ORDER TO HELP INDIVIDUALS WITH ALZHEIMER's, THEIR FAMILIES AND CAREGIVERS NAVIGATE THE LONG AND COMPLICATED JOURNEY THROUGH ALZHEIMER'S DISEASE AND OTHER DEMENTIAS. * INDICATED NAMES THAT ARE TRADEMARKS OF THE ALZHEIMER'S ASSOCIATION. FORM 990, PART VI, LINE 1A Governing body: The Board of Directors of the Alzheimer's Association is the organization's governing body. The Board has delegated authority to its standing and other business committees as described in Article VII of the organizational bylaws. The following excerpt from the Association's bylaws discuss committees of the Board of Directors. Committees of Directors: The Board of Directors shall have the following standing committees: Executive, Finance, Governance and Nominating, Compensation and Audit. Executive Committee: The Executive Committee shall supervise the affairs of the Association, approve expenditures and commitments according to policies prescribed by the Board of Directors, act for and carry out the established policies of the Association as defined by the Board of Directors, including the policies and procedures, report to the Board of Directors at each meeting of the Board of Directors and have such other additional powers as may be by law or resolution of the Board of Directors provided. The Executive Committee shall have and may exercise all authority (including the election of officers other than the Chair, Chair Elect, one or more vice Chairs, Secretary, Treasurer or President and Chief Executive Officer, it being understood that the Executive Committee may elect an interim President and Chief Executive Officer to serve until the next meeting of the Board of Directors) in the management of the Association, subject to the limitations contained in the Delaware corporation law. The Committee's responsibilities shall include, but not be limited to, initiating long-range planning, environmental scanning and performance evaluation; initiating the Board's annual strategic priorities for approval by the Board; assisting the Chair in developing charges to the committees; identifying programmatic and financial indicators of Association performance; conducting the review, performance evaluation and succession planning for the President and CEO; making bylaw recommendations to the Board; reviewing the activities of the Medical and Scientific Advisory Council; and identifying significant issues as that term is defined in Article IX which require consideration by the Association Assembly as described in the same Article and receiving, on behalf of the Board, the Association Assembly's suggestions and recommendations for Board consideration or action. At each of its annual meetings, the Board of Directors by duly adopted resolution shall elect an Executive Committee consisting of not less than eleven or more than fifteen Directors. The Chair, Chair Elect, Vice Chairs, Secretary, Treasurer, Chairs of the Standing Committees and Chairs of the following Committees: Chapter Relations, Development, Diversity and Inclusion, Program, and Public Policy, as well as the Chair of the Medical and Scientific Advisory Council shall be members of the Executive Committee. The Chair of the Board of Directors shall be the Chair of the Executive Committee. The Executive Committee may hold regular meetings monthly or as it may otherwise determine, at such place and at such times and upon such notice as it may determine. Special meetings of the Executive Committee may be called at any time by the Chair or by any three of its members, by notice delivered personally or by mail, telephone, electronic mail or facsimile at least seven days (or at least 48 hours in the case of telephonic meetings) prior to the meeting. A majority of the currently serving members of the Executive Committee shall constitute a quorum for all purposes. FINANCE COMMITTEE: THE FINANCE COMMITTEE SHALL CONSIST OF AT LEAST FIVE DIRECTORS AND SHALL BE CHAIRED BY THE TREASURER. THE FINANCE COMMITTEE SHALL OVERSEE AND REVIEW ALL FINANCIAL REPORTS, ACCOUNTING ACTIVITIES AND INVESTMENT DECISIONS OF THE ASSOCIATION AND ALSO SHALL PREPARE A PROJECTED BUDGET FOR EACH FISCAL YEAR TO BE PRESENTED TO THE BOARD OF DIRECTORS FOR APPROVAL. GOVERNANCE AND NOMINATING COMMITTEE: AT EACH OF ITS ANNUAL MEETINGS, THE BOARD OF DIRECTORS BY DULY ADOPTED RESOLUTION SHALL ELECT A GOVERNANCE AND NOMINATING COMMITTEE CONSISTING OF NOT LESS THAN NINE NOR MORE THAN FIFTEEN INDIVIDUALS CURRENTLY SERVING AS A DIRECTOR. AT LEAST ONE-THIRD OF THE GOVERNANCE AND NOMINATING COMMITTEE SHALL ASSIST THE BOARD IN ENSURING THE SUCCESSFUL GOVERNANCE OF THE ASSOCIATION THROUGH BOARD ASSESSMENT, RECRUITMENT, NOMINATIONS, ORIENTATION AND DEVELOPMENT. THE GOVERNANCE AND NOMINATING COMMITTEE SHALL NOMINATE CANDIDATES FOR DIRECTORS, OFFICERS AND MEMBERS OF THE EXECUTIVE COMMITTEE. THE GOVERNANCE AND NOMINATING COMMITTEE MAY NOMINATE CANDIDATES FOR DIRECTOR EMERITUS, HONORARY DIRECTOR AND ANY ADVISORY OR HONORARY COUNCILS OR COMMITTEES AND APPROVE AND PRESENT TO THE BOARD FOR APPROVAL THE CANDIDATES FOR MEDICAL AND SCIENTIFIC ADVISORY MEMBERSHIP. THE GOVERNANCE AND NOMINATING COMMITTEE ALSO SHALL PROVIDE INPUT TO THE CHAIR ON THE SELECTION OF VICE CHAIRS AND COMMITTEE CHAIRS. COMPENSATION COMMITTEE: A COMPENSATION COMMITTEE WHICH SHALL RECOMMEND SALARY AND BENEFITS FOR THE PRESIDENT AND CEO AND SENIOR OFFICERS OF THE ASSOCIATION; HELP ENSURE SUCCESSION PLANS ARE IN PLACE FOR KEY POSITIONS IN THE ASSOCIATION AND PROVIDE OVERSIGHT ON THE RETIREMENT PROGRAMS OFFERED BY THE ASSOCIATION TO ITS EMPLOYEES. AUDIT COMMITTEE: THE AUDIT COMMITTEE SHALL BE RESPONSIBLE FOR RECOMMENDING AN AUDITOR TO THE BOARD OF DIRECTORS AND SHALL OVERSEE THE ACTIVITIES OF ANY INTERNAL AUDITOR OF THE ASSOCIATION. THE COMMITTEE SHALL SEE THAT AN ANNUAL AUDIT IS PREPARED BY AN INDEPENDENT FIRM OF CERTIFIED PUBLIC ACCOUNTANTS SELECTED BY THE BOARD OF DIRECTORS AND, UPON RECEIVING SUCH AUDITOR'S REPORT, THE COMMITTEE SHALL PREVIEW THE AUDIT REPORT FOR SUBMISSION TO THE BOARD OF DIRECTORS EACH YEAR. THE COMMITTEE SHALL REVIEW THE FINANCIAL REPORTS OF THE ASSOCIATION, ITS SYSTEM OF INTERNAL CONTROLS, AND THE AUDIT PROCESS, INCLUDING THE REVIEW OF THE ACTIVITIES OF THE MEDICAL AND SCIENTIFIC ADVISORY COUNCIL. THE AUDIT COMMITTEE SHALL HAVE AT LEAST FIVE MEMBERS, ALL OF WHOM ARE MEMBERS OF THE BOARD OF DIRECTORS AND THE MAJORITY OF WHOM HAVE APPROPRIATE FINANCIAL EXPERTISE. AT LEAST ONE MEMBER OF THE AUDIT COMMITTEE SHALL MEET THE REQUIREMENT OF "AUDIT COMMITTEE FINANCIAL EXPERT" AS THEN DEFINED BY THE SECURITIES AND EXCHANGE COMMISSION. THE MAJORITY OF THE MEMBERS OF THE AUDIT COMMITTEE MAY NOT CONCURRENTLY SERVE ON THE FINANCE COMMITTEE AND THE TREASURER AND CHAIR OF THE FINANCE COMMITTEE MAY NOT SERVE CONCURRENTLY ON THE AUDIT COMMITTEE. OTHER COMMITTEES: IN ADDITION TO THE STANDING COMMITTEES, OTHER COMMITTEES MAY BE DESIGNATED BY RESOLUTION ADOPTED BY A MAJORITY OF THE DIRECTORS PRESENT AT ANY MEETING. OTHER COMMITTEES SHALL INCLUDE, BUT NOT BE LIMITED TO, THE FOLLOWING BUSINESS COMMITTEES: A. A CHAPTER RELATIONS COMMITTEE WHICH SHALL RECOMMEND AND MONITOR CONSISTENT, PREDICTABLE AND ACCOUNTABLE BOARD POLICY IN AFFILIATE RELATIONS. B. A DEVELOPMENT COMMITTEE WHICH SHALL ADVISE THE BOARD ON PHILANTHROPIC GIVING TO THE ASSOCIATION AND RECOMMEND FUNDRAISING POLICIES. C. A PROGRAM COMMITTEE WHICH SHALL RECOMMEND FOR BOARD CONSIDERATION AND APPROVAL POLICY ISSUES RELATED TO MARKET AND NEEDS ASSESSMENT, PROGRAMS AND SERVICES, QUALITY AND STANDARDS AND RELATED MATTERS. D. A PUBLIC POLICY COMMITTEE WHICH SHALL PROVIDE GUIDANCE TO THE BOARD ON FEDERAL, STATE AND LOCAL PUBLIC POLICY ISSUES AND STRATEGIES INCLUDING RESEARCH FUNDING, HEALTH CARE, LONG TERM CARE, AND PUBLICLY FUNDED CARE AND SUPPORT PROGRAMS. E. A DIVERSITY & INCLUSION COMMITTEE WHICH SHALL HELP ENSURE THAT THE ALZHEIMER'S ASSOCIATION SERVES AND REFLECTS DIVERSE COMMUNITIES, SHALL WORK WITH THE NATIONAL BOARD OF DIRECTORS AND OTHER COMMITTEES TO FOSTER DIVERSITY AND INCLUSION WITH RESPECT TO THE ASSOCIATION STRATEGIC PLAN AND SHALL REPORT ON PROGRESS THE ASSOCIATION AND BOARD ARE MAKING ON ACHIEVING THE ASSOCIATION'S DIVERSITY AND INCLUSION STRATEGIC GOALS. FORM 990, PART VI, LINE 11B FORM 990 REVIEW PROCESS The Organization undergoes a thorough review process before filing the return. The Audit Committee discusses and reviews the form before it is provided to the officers and full Board of Directors. All officers and the full Board of Directors are provided a copy for their review and have the opportunity to comment before the Form 990 is filed. FORM 990, PART VI, LINE 12C Conflict of Interest Policy Monitoring & Enforcement The Alzheimer's Association conflict of interest policy is described in Article XIII, Section 2 of the organizational bylaws. The responsibility for disclosing any known or reasonably foreseen actual or potential conflicts of interest shall be upon the interested party whose interests are or may appear to be in conflict with the Association. All interested parties are required to file with the Association a disclosure statement prior to such individual commencing his or her service with the Association and thereafter shall file with the Association an updated disclosure statement as may be required from time to time by the Board of Directors or its committee designee and in no event less often than annually. As cited from Article XIII, Section 2 of the bylaws, interested persons or chapter representative shall disclose any conflict and shall not vote on a matter and further if requested by the chair or resolution of the Board shall leave the room in which the Board or committee is meeting and shall not participate in any deliberation or decision regarding the matter under consideration. The minutes shall reflect that the conflict of interest was disclosed and the interested person or chapter representative did not participate in any discussion of the matter and did not vote on the matter in person or by proxy. When any such conflict of interest is relevant to a matter requiring action by the Board of Directors or any committee of the Board, the interested person or chapter shall disclose such conflict to the Board of Directors or such committee and shall not vote on the matter. Further the interested person or representative from a chapter having a conflict if requested by the Chair or resolution of the Board shall leave the room in which the Board or the committee is meeting and shall not participate in any deliberation or decision regarding the matter under consideration. When there is a doubt as to whether a conflict of interest exists, the matter shall be resolved by a vote of the Board of Directors or the committee, as the case may be, excluding the interested person or representative from a chapter concerning whom the doubt has arisen. Copies of the Alzheimer's Association bylaws, including the conflict of interest policy, are provided to all Board Directors no less than annually. Board Director disclosure statements are submitted no less than annually. Potential conflicts disclosed by Board Directors or candidates for election to the Board are reviewed by the Governance and Nominating Committee, which reports no less than annually on its review to the full Board. As documented in the meeting minutes, at the start of each meeting of the Board of Directors as well as each meeting of the Executive Committee, the agenda is reviewed and all Directors in attendance are reminded of the Conflict of Interest Policy and advised to disclose any potential conflicts should they exist or arise. FORM 990, PART VI, LINE 15A & 15B PROCESS FOR DETERMINING COMPENSATION Compensation is established for the CEO by the Compensation Committee and the Executive Committee after a thorough salary/market review conducted by outside compensation consultants. For the CEO position, the gathering of relevant comparability data from independent sources occurred in 2016. The process was conducted in a manner intended to qualify for the rebuttable presumption of reasonableness under the Intermediate Sanctions Rules. As to the members of the senior management team other than the CEO, annually updated market data is also provided by the outside compensation consultant, so that the updated market data can be used in setting reasonable compensation for each member of the senior management team. Each year the Compensation Committee evaluates the CEO's performance through a robust assessment process which includes collection, interviews and performance evaluation comparing results to goals. The Committee and Chair of the Board use this data to determine incentive compensation eligibility. The senior staff has a comprehensive performance evaluation and compensation review done at the end of each fiscal year. These include a self-assessment and evaluation by the CEO. Updated market data for use in setting reasonable compensation is provided by a national compensation consulting firm to the Compensation Committee for confirmation of reasonableness using a process designed to qualify for the rebuttable presumption of reasonableness (including contemporaneous documentation in the Committee's minutes). For fiscal year 2017, the salary and total compensation package of the CEO was benchmarked by SULLIVAN COTTER. Compensation is contemporaneously documented in the Compensation Committee minutes. FORM 990, PART VI, SECTION C, LINE 18 HOW DOCUMENTS ARE MADE AVAILABLE TO THE PUBLIC The organization makes its Form 990 available to the general public by posting on the website at www.alz.org and upon request. The organization makes its Form 1023 available to the general public upon request. FORM 990, PART VI, SECTION C, LINE 19 HOW DOCUMENTS ARE MADE AVAILABLE TO THE PUBLIC The organization's audited financial statements are made available to the general public by posting on the organization's website at www.alz.org and upon request. The organization makes its governing documents and conflict of interest policy available to the general public upon request. FORM 990, PART XI, LINE 9 OTHER CHANGE IN NET ASSETS OR FUND BALANCE ACQUISITION OF DISSOLVED CHAPTERS $130,859,707 CHANGE IN PERPETUAL TRUST $1,492,475 CHANGE IN SPLIT INTEREST $378,795 BAD DEBT $(1,617,886) MISCELLANEOUS $(2,415) ------------ TOTAL $131,110,676 General Note Effective July 1, 2016, one chapter dissolved and 46 chapters merged with the Association to create a united Alzheimers Association. Total assets acquired from the 47 chapters were approximately $152,004,000 and net assets acquired were approximately $130,859,000. The Association oversees the operations and activities for 81 chapters to facilitate strategic alignment, deliver on the overarching Association-wide strategic objectives and priority activities, and to ensure coverage for all geographic territories. Alzheimer's Impact Movement (AIM) 225 N Michigan Ave Fl 17 Chicago IL 60601 271961435 SOC Welfare IL 501(C)(4) Alz Assoc true Alzheimer's Association International 181 Bay St Brookfield Pl 2100 Toronto Ontario CA M5J2T3 999999999 PUBLIC CHAR CA 501(C)(3) Alz Assoc true false true false false false false false false false false false false false true true false false false false Alzheimer's Impact Movement B 1433291 FMV Alzheimer's Impact Movement O 130504 FMV Schedule R, Part V, Line 2 AMOUNT INVOLVED IN RELATIONSHIP The Alzheimer's Association granted funds to Alzheimer's Impact Movement (AIM) for public policy division activities in fiscal year 2017 to support priorities identified in the Alzheimer's Association's strategic plan. This grant is restricted to the following 501(c)3 activities and the ancillary activities necessary to accomplish specific goals including: Implementation of the National Alzheimer's Project Act (Recognizing this growing Alzheimer's crisis, Congress unanimously passed and the President signed into law the National Alzheimer's Project Act - NAPA); increasing the commitment to Alzheimer's research; expanding education efforts and caregiver support services; expanding diagnosis and planning.